[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo

By Susan E. Clare

Susan Clare, Indiana University School of Medicine, Indianapolis, IN

Published on

Abstract

Parsing error resulted in empty content. Displaying raw markup below.

<!--<p><iframe width="560" height="315" src="http://www.youtube.com/embed/SNF_5f_-7kM" frameborder="0" allowfullscreen></iframe>
</p>-->

Bio

Dr. Clare is the co-Principal Investigator of the Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer Center. The Komen-Indiana Bank is the only tissue biorepository in the world established for the acquisition of normal breast tissue, i.e., from volunteer donors with out evidence of disease. She and her laboratory colleagues are members of an NIH R-01 funded Bioengineering Research Partnership, which is developing a nanobiochip for the functional assay of signal transduction pathways. Dr. Clare and her group are also investigating using monocytes/macropahges as a Trogan Horse to deliver nanoparticles to primary and metastatic lesions.

Source: Dr. Clare's Research Profile

Sponsored by

National Science Foundation, National Science Council of Taiwan, and the National Institutes of Health.

Cite this work

Researchers should cite this work as follows:

  • Susan E. Clare (2012), "[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo," http://nanohub.org/resources/14921.

    BibTex | EndNote

Submitter

Charlie Newman, NanoBio Node

University of Illinois at Urbana-Champaign

Tags